Heidelberg Pharma AG
XETRA:HPHA
Heidelberg Pharma AG
EPS (Diluted)
Heidelberg Pharma AG
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Heidelberg Pharma AG
XETRA:HPHA
|
EPS (Diluted)
€0
|
CAGR 3-Years
10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
EPS (Diluted)
€3
|
CAGR 3-Years
300%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
EPS (Diluted)
-€12
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
CureVac NV
NASDAQ:CVAC
|
EPS (Diluted)
-€1
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
EPS (Diluted)
-€1
|
CAGR 3-Years
35%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
EPS (Diluted)
€3
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
18%
|
See Also
What is Heidelberg Pharma AG's EPS (Diluted)?
EPS (Diluted)
-0.4
EUR
Based on the financial report for Nov 30, 2023, Heidelberg Pharma AG's EPS (Diluted) amounts to -0.4 EUR.
What is Heidelberg Pharma AG's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-1%
Over the last year, the EPS (Diluted) growth was 17%. The average annual EPS (Diluted) growth rates for Heidelberg Pharma AG have been 10% over the past three years , -1% over the past five years .